AVA
Atlas Venture Advisors Portfolio holdings
AUM
$424M
This Quarter Return
+139.81%
1 Year Return
+0.16%
3 Year Return
+108.89%
5 Year Return
+64.67%
10 Year Return
–
AUM
$392M
AUM Growth
+$392M
(+431%)
Cap. Flow
+$229M
Cap. Flow
% of AUM
58.51%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
2
Closed
–
Top Buys
| 1 |
DraftKings
DKNG
|
$276M |
Top Sells
| 1 |
Larimar Therapeutics
LRMR
|
$41.3M |
| 2 |
Datadog
DDOG
|
$4.92M |
Sector Composition
| 1 | Consumer Discretionary | 70.3% |
| 2 | Healthcare | 25.25% |
| 3 | Communication Services | 3.19% |
| 4 | Technology | 1.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
DraftKings
DKNG
$23.8B
| $276M | 70.3% | +8,284,008 | New | +$276M |
|
|
TBIO
2
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $70.3M | 17.93% | 3,922,008 | – | – |
|
|
BCYC
3
Bicycle Therapeutics
BCYC
$511M
| $21.4M | 5.47% | 1,362,696 | – | – |
|
4
Roku
ROKU
$14.2B
| $6.73M | 1.72% | 57,707 | – | – |
|
5
Snap
SNAP
$12.1B
| $5.77M | 1.47% | 245,559 | – | – |
|
|
6
Datadog
DDOG
$47.7B
| $4.92M | 1.26% | 56,616 -56,616 | -50% | -$4.92M |
|
|
7
Larimar Therapeutics
LRMR
$310M
| $3.76M | 0.96% | 292,184 -3,214,023 | -92% | -$41.3M |
|
8
Viridian Therapeutics
VRDN
$1.5B
| $3.49M | 0.89% | 3,142,580 | – | – |
|